Novartis now expects its core operating profit to grow in the mid to high teens, after second-quarter results outpaced analysts’ expectations, boosted by revenue from its blockbuster treatments.
Related Posts
Macy’s Says Accounting Employee Hid Up to $154 Million in Delivery Expenses
The retailer delayed its quarterly results after it said an employee hid up to $154 million in delivery expenses over several years, prompting an investigation.
ArcelorMittal Trims Steel Outlook After Earnings Slump
ArcelorMittal reported a 38% fall in second-quarter earnings on lower steel prices and shipments but said it expected demand to improve in the second half […]
Volvo Car Sees Record Earnings Growth but Warns on Sales
Volvo shares rose sharply after the carmaker posted record growth in underlying earnings for the second quarter, and despite warning that potential tariffs from the […]